Harmonizing yin and yang, remodeling the microenvironment: the adjuvant potential of Chinese herbal medicine in tumor immunotherapy
Frontiers in Oncology · 25.03.2026 · 16
DOI: 10.3389/fonc.2026.1806602 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Oncology, online erschienen am 25.03.2026. Verfasst von Xin Gao und 8 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Integration and Innovation of Classic Formula and Modern Chinese Medicine, National Chinmedomics Research Center, National Tr…. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 83 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
With immune checkpoint inhibitors (ICIs) and chimeric antigen receptor T-cell (CAR-T) therapy emerging as the fourth pillar of cancer treatment, modern oncology has entered a new era. However, clinical challenges—including primary/secondary resistance, limited response rates (particularly in “cold tumors”), and potentially severe immune-related adverse events (irAEs)—significantly constrain their applicability and patient benefit. Traditional Chinese medicine (TCM), grounded in its holistic principles of tonifying the body’s resistance while eliminating pathogenic factors and syndrome differentiation, demonstrates unique scientific value and translational potential through multi-component, multi-target synergistic actions. It remodels the tumor immune microenvironment (TME), enhances antitumor immune responses, and mitigates immunotherapy-related toxicities. This review systematically synthesizes current evidence elucidating core mechanisms by which TCM formulas, single compounds, and bioactive components enhance efficacy and reduce toxicity. Regarding efficacy enhancement, we focus on TCM’s role in reversing T-cell exhaustion, reprogramming tumor-associated macrophages (TAMs) and myeloid-derived suppressor cells (MDSCs), inducing immunogenic cell death (ICD), modulating tumor metabolic reprogramming, and optimizing gut microbiota composition to potentiate systemic antitumor immunity. For toxicity reduction, we comprehensively synthesize clinical evidence and pharmacological mechanisms underlying TCM’s mitigation of immune-related pneumonitis, colitis, cardiotoxicity, dermatotoxicity, and myelosuppression. This work establishes a robust theoretical foundation and scientific evidence for novel TCM-integrated strategies in cancer immunotherapy, while outlining future directions in the era of precision medicine.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- State Key Laboratory of Integration and Innovation of Classic Formula and Modern Chinese Medicine, National Chinmedomics Research Center, National Traditional Chinese Medicine (TCM) Key Laboratory of Serum Pharmacochemi…
- State Key Laboratory of Dampness Syndrome of Chinese Medicine, The Second Affiliated Hospital Guangzhou University of Chinese Medicine, Guangzhou, China.
Zitieren
APA
Gao, X., Han, Y., Yang, L., Fang, H., Sun, H., Sun, Y., Yan, G., Kong, L., & Wang, X. (2026). Harmonizing yin and yang, remodeling the microenvironment: the adjuvant potential of Chinese herbal medicine in tumor immunotherapy. Frontiers in Oncology, 16. https://doi.org/10.3389/fonc.2026.1806602
Vancouver
Gao X, Han Y, Yang L, Fang H, Sun H, Sun Y, et al. Harmonizing yin and yang, remodeling the microenvironment: the adjuvant potential of Chinese herbal medicine in tumor immunotherapy. Frontiers in Oncology. 2026;16. doi:10.3389/fonc.2026.1806602
BibTeX
@article{Gao2026,
author = {Gao, Xin and Han, Ying and Yang, Le and Fang, Heng and Sun, Hui and Sun, Ye and Yan, Guangli and Kong, Ling and Wang, Xijun},
title = {Harmonizing yin and yang, remodeling the microenvironment: the adjuvant potential of Chinese herbal medicine in tumor immunotherapy},
journal = {Frontiers in Oncology},
year = {2026},
volume = {16},
doi = {10.3389/fonc.2026.1806602}
}
EUVIMED